Epix names Uprichard president and COO

MR contrast agent developer Epix Medical has appointed Dr. Andrew Uprichard to the position of president and chief operating officer.

Uprichard most recently was COO of ArQule, where he initiated a strategy that helped transform the firm from a chemistry platform company to a drug discovery and development organization, according to Cambridge, MA-based Epix.

By AuntMinnie.com staff writers
July 16, 2004

Related Reading

Epix testing MS-325 for cardiac imaging, July 12, 2004

Epix launches new MS-325 trial, July 8, 2004

Schering submits MS-325 for EU approval, June 7, 2004

Epix raises $96 million, June 4, 2004

Epix floats new debt, June 2, 2004

Copyright © 2004 AuntMinnie.com

Page 1 of 606
Next Page